Globant (NYSE: GLOB) and Inovalon Holdings (NASDAQ:INOV) are both computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, valuation, profitability, analyst recommendations, risk, dividends and earnings.

Analyst Ratings

This is a summary of current ratings for Globant and Inovalon Holdings, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Globant 0 4 4 0 2.50
Inovalon Holdings 1 6 1 0 2.00

Globant presently has a consensus price target of $44.86, indicating a potential upside of 10.19%. Inovalon Holdings has a consensus price target of $14.00, indicating a potential downside of 17.16%. Given Globant’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Globant is more favorable than Inovalon Holdings.

Valuation & Earnings

This table compares Globant and Inovalon Holdings’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Globant $357.94 million 3.97 $51.92 million $0.87 46.79
Inovalon Holdings $419.99 million 5.87 $67.35 million $0.11 153.65

Inovalon Holdings has higher revenue and earnings than Globant. Globant is trading at a lower price-to-earnings ratio than Inovalon Holdings, indicating that it is currently the more affordable of the two stocks.


This table compares Globant and Inovalon Holdings’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Globant 8.61% 15.08% 10.96%
Inovalon Holdings 4.13% 5.17% 3.38%

Insider and Institutional Ownership

66.1% of Globant shares are owned by institutional investors. Comparatively, 28.7% of Inovalon Holdings shares are owned by institutional investors. 48.3% of Inovalon Holdings shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Volatility & Risk

Globant has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500. Comparatively, Inovalon Holdings has a beta of 1.31, indicating that its stock price is 31% more volatile than the S&P 500.


Globant beats Inovalon Holdings on 8 of the 14 factors compared between the two stocks.

Globant Company Profile

Globant S.A. is a digitally native technology services company. The Company’s principal operating subsidiary is based in Buenos Aires, Argentina. During the year ended December 31, 2015, 83.7% of its revenues were generated by clients in North America, 11.0% in Latin America and Asia, and 5.3% in Europe. It builds digital journeys, which consists of different software products, including mobile apps, Web apps, sensors and other software and hardware appliances that work orchestrated by a backend that uses big data and fast data to create a understanding of each consumer and how to act upon each scenario. The Company delivers digital journeys with a comprehensive approach that includes Stay Relevant, which helps its customers stay fit for the future of their industries; Discover, which think and conceive specific digital journeys for each customer; Build, which creates each digital journey leveraging the work of its Studios, its services over platforms and its agile pods methodologies.

Inovalon Holdings Company Profile

Inovalon Holdings, Inc. (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem. The Company serves clients across the healthcare industry, which includes health plans and provider organizations, pharmaceutical, medical device, and diagnostics companies. It provides technology that supports approximately 500 healthcare organizations. Inovalon’s platforms are informed by data pertaining to more than 856,000 physicians, 375,000 clinical facilities, and more than 158 million Americans.

Receive News & Ratings for Globant S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globant S.A. and related companies with Analyst Ratings Network's FREE daily email newsletter.